Keywords: gsk, reduces, ceo, remuneration, package, andrew, witty

GSK reduces CEO remuneration package

Article | 16 March 2009

Print This

Andrew Witty, the chief executive of UK drug major GlaxoSmithKline, will receive a 17.6% pay rise to increase his basic wage ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in